CONDUIT PHARMACEUTICALS
(NASDAQ: CDT)
Conduit Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of clinical assets to address the unmet medical needs of patients, through exclusive relationships in the areas of autoimmune disease and idiopathic male infertility. The company is headquartered in Naples, FL.
0.075
+0.009
(+13.64%)
Range
0.062 - 0.076
(22.58%)
Open
0.062
Previous Close
0.066
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
18,337,113
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis